UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 126

Sortiert nach

Prognosis after neoadjuvant chemoradiation or chemotherapy for locally advanced gastro-oesophageal junctional adenocarcinoma

British journal of surgery, 2021-11, Vol.108 (11), p.1332

2021

Volltextzugriff (PDF)

Robot-assisted minimally invasive esophagectomy (RAMIE): tips and tricks from the bedside assistant view—expert experiences

Diseases of the esophagus, 2020-11, Vol.33 (Supplement_2)

2020

Volltextzugriff (PDF)

Does neoadjuvant therapy for esophageal cancer increase postoperative morbidity or mortality?

Diseases of the esophagus, 2015-10, Vol.28 (7), p.644-651

2015

Volltextzugriff (PDF)

National guidelines may reduce socioeconomic disparities in treatment selection for esophageal cancer

Diseases of the esophagus, 2019-05, Vol.32 (5)

2019

Volltextzugriff (PDF)

Outcomes of Surgery for Benign Foregut Disease in the Elderly: A NSQIP Analysis

The Journal of surgical research, 2014-02, Vol.186 (2), p.628-629

2014

Volltextzugriff (PDF)

Clinical tools do not predict pathological complete response in patients with esophageal squamous cell cancer treated with definitive chemoradiotherapy

Diseases of the esophagus, 2014-05, Vol.27 (4), p.355-359

2014

Volltextzugriff (PDF)

SAGES guidelines for the use of peroral endoscopic myotomy (POEM) for the treatment of achalasia

Surgical endoscopy, 2021-05, Vol.35 (5), p.1931-1948

2021

Volltextzugriff (PDF)

FOLFOX-Based Chemoradiation as Non-Operative Management for Esophageal Adenocarcinoma

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.e167

2022

Volltextzugriff (PDF)

Robot-Assisted Minimally Invasive Esophagectomy versus Open Esophagectomy for Esophageal Cancer: A Systematic Review and Meta-Analysis

Cancers, 2022-06, Vol.14 (13), p.3177

2022

Volltextzugriff (PDF)

Risk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer

JAMA surgery, 2021-09, Vol.156 (9), p.836

2021

Volltextzugriff (PDF)

Phase II Trial Evaluating Esophageal Anastomotic Reinforcement with a Biologic, Degradable, Extracellular Matrix after Total Gastrectomy and Esophagectomy

Journal of the American College of Surgeons, 2022-05, Vol.234 (5), p.910-917

2022

Volltextzugriff (PDF)

P-63 MATTERHORN: A phase 3 study of efficacy and safety of neoadjuvant-adjuvant durvalumab and FLOT chemotherapy in resectable gastric and gastroesophageal junction cancer

Annals of oncology, 2021-07, Vol.32, p.S118

2021

Volltextzugriff (PDF)

SO-6 Novel frailty index predicts short-term outcomes after esophagectomy in elderly patients with esophageal cancer

Annals of oncology, 2022-06, Vol.33, p.S358

2022

Volltextzugriff (PDF)

EP07.04-04 High-Risk Clinicopathologic and Genomic Features of Recurrence in Stage I Lung Adenocarcinoma

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S544-S545

2023

Volltextzugriff (PDF)

129O Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Interim results of the global, phase III MATTERHORN study

Annals of oncology, 2023-11, Vol.34, p.S1520-S1521

2023

Volltextzugriff (PDF)

LBA73 Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Interim results of the global, phase III MATTERHORN study

Annals of oncology, 2023-10, Vol.34, p.S1315-S1316

2023

Volltextzugriff (PDF)

Survival and Patterns of Failure in Oligometastatic Esophagogastric Cancer

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e623-e623

2020

Volltextzugriff (PDF)

Botulinum toxin injection vs laparoscopic myotomy for the treatment of esophageal achalasia: Economic analysis of a randomized trial

Surgical endoscopy, 2004-04, Vol.18 (4), p.691-695

2004

Volltextzugriff (PDF)

O-5 Frequency of minimal residual disease as measured by ctDNA in mismatch repair deficient tumors following curative resection

Annals of oncology, 2021-07, Vol.32, p.S219

2021

Volltextzugriff (PDF)

Genetic Determinants of Chemoradiation Response and Survival in Locally Advanced Esophageal Carcinoma Treated with Trimodality Therapy

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.E194-E195

2019

Volltextzugriff (PDF)

Prognosis after neoadjuvant chemoradiation or chemotherapy for locally advanced gastroesophageal junction adenocarcinoma

British journal of surgery, 2021-11, Vol.108 (11), p.1332-1340

2021

Volltextzugriff (PDF)

Tailored approach to Zenker's diverticula

Surgical endoscopy, 2003, Vol.17 (1), p.129-133

2003

Volltextzugriff (PDF)

A prospective multicenter study on laparoscopic treatment of gastroesophageal reflux disease in Italy : Type of surgery, conversions, complications, and early results

Surgical endoscopy, 2000-03, Vol.14 (3), p.282-288

2000

Volltextzugriff (PDF)

A23 A Genomically Adjusted Clinicopathologic Model Predicts Recurrence in Resected Early-Stage Lung Squamous Cell Carcinoma

Journal of thoracic oncology, 2020-02, Vol.15 (2), p.S19-S20

2020

Volltextzugriff (PDF)

Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia

Annals of surgery, 2004-03, Vol.239 (3), p.364-370

2004

Volltextzugriff (PDF)

1 – 25 von 126

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(97)

Publikationsform

Artikel
(125)
Buchkapitel
(1)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Prognosis after neoadjuvant chemoradiation or chemotherapy for locally advanced gastro-oesophageal junctional adenocarcinoma

Robot-assisted minimally invasive esophagectomy (RAMIE): tips and tricks from the bedside assistant view—expert experiences

Does neoadjuvant therapy for esophageal cancer increase postoperative morbidity or mortality?

National guidelines may reduce socioeconomic disparities in treatment selection for esophageal cancer

Outcomes of Surgery for Benign Foregut Disease in the Elderly: A NSQIP Analysis

Clinical tools do not predict pathological complete response in patients with esophageal squamous cell cancer treated with definitive chemoradiotherapy

SAGES guidelines for the use of peroral endoscopic myotomy (POEM) for the treatment of achalasia

FOLFOX-Based Chemoradiation as Non-Operative Management for Esophageal Adenocarcinoma

Robot-Assisted Minimally Invasive Esophagectomy versus Open Esophagectomy for Esophageal Cancer: A Systematic Review and Meta-Analysis

Risk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer

Phase II Trial Evaluating Esophageal Anastomotic Reinforcement with a Biologic, Degradable, Extracellular Matrix after Total Gastrectomy and Esophagectomy

P-63 MATTERHORN: A phase 3 study of efficacy and safety of neoadjuvant-adjuvant durvalumab and FLOT chemotherapy in resectable gastric and gastroesophageal junction cancer

SO-6 Novel frailty index predicts short-term outcomes after esophagectomy in elderly patients with esophageal cancer

EP07.04-04 High-Risk Clinicopathologic and Genomic Features of Recurrence in Stage I Lung Adenocarcinoma

129O Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Interim results of the global, phase III MATTERHORN study

LBA73 Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Interim results of the global, phase III MATTERHORN study

Survival and Patterns of Failure in Oligometastatic Esophagogastric Cancer

Botulinum toxin injection vs laparoscopic myotomy for the treatment of esophageal achalasia: Economic analysis of a randomized trial

O-5 Frequency of minimal residual disease as measured by ctDNA in mismatch repair deficient tumors following curative resection

Genetic Determinants of Chemoradiation Response and Survival in Locally Advanced Esophageal Carcinoma Treated with Trimodality Therapy

Prognosis after neoadjuvant chemoradiation or chemotherapy for locally advanced gastroesophageal junction adenocarcinoma

Tailored approach to Zenker's diverticula

A prospective multicenter study on laparoscopic treatment of gastroesophageal reflux disease in Italy : Type of surgery, conversions, complications, and early results

A23 A Genomically Adjusted Clinicopathologic Model Predicts Recurrence in Resected Early-Stage Lung Squamous Cell Carcinoma

Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia

Suchergebnisse filtern